Literature DB >> 10393787

Complications and their management in tympanomastoid surgery.

F Mancini1, A K Taibah, M Falcioni.   

Abstract

Chronic diseases of the ear and their surgical treatment can endanger the delicate structures of the temporal bone in close relationship with the middle ear. The experience and expertise of the otologic surgeon, based on perfect knowledge of the complex anatomy of the whole temporal bone, are unfortunately built up partly through the management of complications encountered in tympanomastoid surgery and may require knowledge of basic neuro-otologic procedures. Paralysis and paresis of the facial nerve and labyrinthine, and dural and vascular injuries may have consequences not only in the final result of surgery but also in endangering the patient's life. All major complications are discussed and some possible treatments are proposed. Minor complications affecting the temporomandibular joint, the dura, the external auditory canal, and the bony canal wall are also covered, along with some suggestions on how to keep these consequences within reasonable percentages.

Entities:  

Mesh:

Year:  1999        PMID: 10393787     DOI: 10.1016/s0030-6665(05)70153-5

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

Review 1.  [Acute complications during middle ear surgery: part 1: Problems during tympanoplasty--what to do?].

Authors:  K Schwager
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

2.  Surgical importance of the tympanic bone: multidetector computed tomography findings.

Authors:  Şahinde Atlanoğlu; Muhammed Fatih Topuz
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-06-30

3.  Morphological validation of a novel bi-material 3D-printed model of temporal bone for middle ear surgery education.

Authors:  Jordan Chauvelot; Cedric Laurent; Gaël Le Coz; Jean-Philippe Jehl; Nguyen Tran; Marta Szczetynska; Abdelhadi Moufki; Anne-Sophie Bonnet; Cecile Parietti-Winkler
Journal:  Ann Transl Med       Date:  2020-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.